PubMed İndeksli Yayınlar Koleksiyonu by Institution Author "Sarici, Furkan"

Now showing items 1-1 of 1

Efficacy and safety evaluation of eribulin-trastuzumab combination therapy with heavily pretreated HER2-positive metastatic breast cancer

Sarici, Furkan; Altundag, Kadri (Zerbinis Publications, 2020)

Purpose: Eribulin mesylate is a non-taxane microtubule inhibitor which is a synthetic holichondrin B analog that can be used after anthracycline and taxane treatment in patients with metastatic breast cancer. We aimed to ...